Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

The ‘KojoX’ method of cloning facilities around the globe keeps the CDMO agile in an industry fractured by geopolitical ...

The sheer growth of small biotechs and mid‑sized pharma companies entering the field has reshaped expectations of Contract Development and Manufacturing Organisations (CDMOs).

RICHMOND, Va., January 14, 2026 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced a major advancement in AI-driven Active ...

With multiple high-profile production pacts already in the books for 2024, CDMO Samsung Biologics has hooked another big one. Samsung has locked down a $1.2 billion contract with an unnamed Asia-based ...

With new digs in Tampa, Florida, now open and the one-year anniversary of its $16.5 billion acquisition fast approaching, Catalent is adopting a fresh look as it charts the next chapter of its CDMO ...

Ajinomoto Bio-Pharma Services recognized in "Global Biologics" category Forge Biologics, a member of Ajinomoto-Bio-Pharma Services, recognized in "Global Cell & Gene Therapy" category SAN DIEGO, March ...

Altitude Marketing released its 2026 CDMO Marketing Trends Report, a quantitative analysis of marketing practices and ...

The "Semi-Solid Dosage CDMO Market Size, Share & Trends Analysis Report By Route of Administration (Topical, Transdermal), By Product, By Service, By End Use, By Region, And Segment Forecasts, 2025 - ...